Managers

Quan Capital targets $300 mln for second healthcare fund

Quan Capital is seeking to raise $300 million for its second fund, according to an SEC filing. Based in China, Quan Capital is a venture firm that invests in healthcare, pharmaceutical and biotech startups.

Tempus picks up $110 mln

Chicago-based Tempus, a data-driven precision medicine company, has raised $110 million in financing. The investors included Baillie Gifford, T. Rowe Price, Revolution Growth and New Enterprise Associates.

Lunaphore fetches about $5.5 mln Series B

Lunaphore Technologies SA, a Swiss medtech firm, has raised about $5.5 million in Series B funding. The investors included Occident Group, Zürcher Kantonalbank and investment funds from Asia, Switzerland and United Kingdom.

Powerplant Ventures targets $100 mln for second fund

Powerplant Ventures is seeking to raise $100 million for its second fund, according to an SEC filing. Based in Manhattan Beach, California, the emerging-stage growth equity firm invests in consumer food, beverage, and foodservice companies.

VC-backed 10x Genomics buys Epinomics

Genomics company 10x Genomics has acquired Epinomics, a provider of epigenetic technology. No financial terms were disclosed. 10x Genomics' backers include Venrock, Softbank, Foresite Capital, Fidelity and Meritech Capital. And, Epinomics' backers included Lightspeed Venture Partners, Felicis Ventures and Founders Fund.

Biotech firm RootPath picks up $7 mln

Cambridge, Massachusetts-based RootPath, a biotechnology company, has raised $7 million in seed funding. Sequoia China led the round with participation from Volcanics Venture, BV and Nest.Bio Ventures. RootPath was launched in 2017 by life sciences venture capital and incubation firm Nest.Bio.

Eventbrite moves toward a $2 bln-plus IPO

Exit markets build momentum in cybersecurity

Cybersecurity investing surges (again)

As elections approach, advisers and investors must heed SEC pay-to-play rule